GlassScriptPhysician profile
Lisa Patel
NPI 1629533294
$976.86
in general payments reported to CMS, 2019-2025
13 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.26 · 2023: $216 · 2024: $587 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $239.15 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $219.17 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $157.71 | 2023-2025 | Freestyle Libre 3 |
| Pfizer INC. | $86.40 | 2024-2025 | |
| Exact Sciences Corporation | $50.32 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $46.62 | 2023-2024 | |
| Tactile Systems Technology INC | $38.36 | 2024 | Flexitouch Plus, Entre Plus |
| Glaxosmithkline, LLC. | $34.23 | 2023 | Bexsero, Shingrix |
| Astrazeneca Pharmaceuticals LP | $32.13 | 2024 | Farxiga |
| Phadia US INC. | $19.00 | 2025 | Immunocap |
| Merck Sharp & Dohme LLC | $18.61 | 2023 | Vaxelis, Gardasil 9, Pneumovax 23 |
| Inspire Medical Systems, INC. | $17.84 | 2024 | Inspire |
| Ibsa Pharma INC. | $17.32 | 2024 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.